Figure 1
Figure 1. Pt-Cy preferentially depletes proliferating effector/memory T cells. (A) Representative (out of 10) Ki-67 and HLA-DR expression in PB CD3+ T cells at day 3 and day 7 post–haplo-HSCT. (B) Mean ± standard error of the mean (SEM) frequency (n = 22; each dot represents a patient) of Ki-67+ T cells with a given differentiation phenotype at day 3 post–haplo-HSCT. +P < .05 vs TRTE; *P < .05 vs TN; Wilcoxon test. (C) Mean ± SEM frequency (n = 23) of CD4+ and CD8+ T cells at day 3 and day 7 post–haplo-HSCT. P < .05 vs day 3; Wilcoxon test. (D) CFSE dilution and CD25 expression by TN and TMEM following incubation with auto-APCs or allo-APCs for 3 days. The gate in black identifies CFSElo proliferating (ie, alloreactive) cells, whereas that in gray CFSEhi nonproliferating cells. (E) CD45RO expression by CFSElo and CFSEhi cells, identified as in panel D, originally sorted as TN (top) or TMEM (bottom).

Pt-Cy preferentially depletes proliferating effector/memory T cells. (A) Representative (out of 10) Ki-67 and HLA-DR expression in PB CD3+ T cells at day 3 and day 7 post–haplo-HSCT. (B) Mean ± standard error of the mean (SEM) frequency (n = 22; each dot represents a patient) of Ki-67+ T cells with a given differentiation phenotype at day 3 post–haplo-HSCT. +P < .05 vs TRTE; *P < .05 vs TN; Wilcoxon test. (C) Mean ± SEM frequency (n = 23) of CD4+ and CD8+ T cells at day 3 and day 7 post–haplo-HSCT. P < .05 vs day 3; Wilcoxon test. (D) CFSE dilution and CD25 expression by TN and TMEM following incubation with auto-APCs or allo-APCs for 3 days. The gate in black identifies CFSElo proliferating (ie, alloreactive) cells, whereas that in gray CFSEhi nonproliferating cells. (E) CD45RO expression by CFSElo and CFSEhi cells, identified as in panel D, originally sorted as TN (top) or TMEM (bottom).

Close Modal

or Create an Account

Close Modal
Close Modal